Detection of the ABI2 protein by IHC staining showed that the protein expression of ABI2 in clinical NPC samples was remarkably reduced in N2-3 stages compared with N0-1 stages (Figure 3I). Here, ABI2 is linked to nasopharyngeal carcinoma.